Highlights
- •Hypertension is a leading risk factor for cardiovascular disease in women.
- •Sex-specific factors, such as polycystic ovary syndrome, hypertension in pregnancy and menopause, modulate the risk of hypertension across the lifespan.
- •By age 75, the prevalence of hypertens ion in women is higher than in men.
Abstract
Hypertension is a leading risk factor for cardiovascular disease in women. Both traditional
and sex-specific risk modifiers occurring from menarche to pregnancy to menopause
modulate the risk of hypertension and adverse cardiovascular events. This review provides
a narrative summary of risk and treatment of hypertension in women across the lifespan,
from adolescence to the post-menopausal period, where each period represents a potential
window for risk assessment, diagnosis, and appropriate treatment. Management of hypertension
throughout a woman's life must be included in a holistic cardiovascular prevention
approach for women in order to prevent future cardiovascular complications.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to MaturitasAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The lancet women and cardiovascular disease commission: reducing the global burden by 2030.Lancet. 2021; 397: 2385-2438
- Hypertension in women: recent advances and lingering questions.Hypertension. 2017; 70: 19-26
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.Lancet. 2004; 364: 937-952
- Menopause and cardiovascular disease.Post Reprod. Health. 2018; 24: 44-49
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines.J. Am. Coll. Cardiol. 2018; 71: 2199-2269
- 2018 ESC/ESH guidelines for the management of arterial hypertension.Eur. Heart J. 2018; 39: 3021-3104
- Hypertension in women: should there be a sex-specific threshold?.Eur. Cardiol. 2021; 16e38
- Hypertension-mediated organ damage and established cardiovascular disease in patients with hypertension: the China hypertension survey, 2012–2015.J. Hum. Hypertens. 2021;
- Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the losartan intervention for endpoint reduction in hypertension (LIFE) study.Hypertension. 2002; 39: 739-743
- Lack of reduction of left ventricular mass in treated hypertension: the strong heart study.J. Am. Heart Assoc. 2013; 2e000144
- Sex difference in cardiovascular risk: role of pulse pressure amplification.J. Am. Coll. Cardiol. 2012; 59: 1771-1777
- Gender differences in left ventricular structure and function during antihypertensive treatment: the losartan intervention for endpoint reduction in hypertension study.Hypertension. 2008; 51: 1109-1114
- Gender-specific therapeutic approach in arterial hypertension - challenges ahead.Pharmacol. Res. 2019; 141: 181-188
- Risk of incident myocardial infarction by gender: interactions with serum lipids, blood pressure and smoking. The Tromso study 1979–2012.Atherosclerosis. 2017; 261: 52-59
- Sex differences in risk factors for myocardial infarction: cohort study of UK biobank participants.BMJ. 2018; 363k4247
- Factors associated with increase in blood pressure and incident hypertension in early midlife: the Hordaland Health Study.Blood Press. 2020; 29: 267-275
- A randomized trial of intensive versus standard blood-pressure control.N. Engl. J. Med. 2015; 373: 2103-2116
- Hypertension across a woman's life cycle.J. Am. Coll. Cardiol. 2018; 71: 1797-1813
- High blood pressure in children and adolescents.Am. Fam. Phys. 2018; 98: 486-494
- Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US registry.Pediatr. Nephrol. 2016; 31: 641-650
- The Canadian Women's Heart Health Alliance Atlas on the epidemiology, diagnosis, and management of cardiovascular disease in women - chapter 4: sex- and gender-unique disparities: CVD across the lifespan of a woman.CJC Open. 2022; 4: 115-132
- Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-art review.J. Am. Coll. Cardiol. 2020; 75: 2602-2618
- Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression.Reprod. Biol. Endocrinol. 2020; 18: 23
- Preeclampsia and long-term coronary artery disease: how to minimize the odds?.Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; 255: 253-258
- Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review.J. Am. Coll. Cardiol. 2020; 76: 1690-1702
- ACOG practice bulletin, number 222.Obstet. Gynecol. 2020; 135: e237-e260
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and Management of High Blood Pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines.Circulation. 2018; 138: e426-e483
- Treatment for mild chronic hypertension during pregnancy.N. Engl. J. Med. 2022; 386: 1781-1792
- Less-tight versus tight control of hypertension in pregnancy.N Engl J Med. 2015; 372: 2367-2368
- Hypertension Canada's 2018 guidelines for the management of hypertension in pregnancy.Can. J. Cardiol. 2018; 34: 526-531
- Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial.Hypertens. Pregnancy. 2020; 39: 393-398
- Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: a multicenter randomized clinical trial.Hypertens. Pregnancy. 2019; 17: 54-58
- Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia.N Engl J Med. 2017; 377: 613-622
- Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?.Am. J. Obstet. Gynecol. 2020; 222: 437-450
- Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race.Am. J. Obstet. Gynecol. 2020; 2100184
- The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention.Int. J. Gynaecol. Obstet. 2019; 145: 1-33
- Randomized interventional study on prediction of Preeclampsia/Eclampsia in women with suspected preeclampsia: INSPIRE.Hypertension. 2019; 74: 983-990
- Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study.BMJ. 2017; 358j3078
- Postpartum lifestyle interventions among women with pre-eclampsia: a scoping review protocol.BMJ Open. 2020; 10e035507
- The Canadian Women's Heart Health Alliance Atlas on the epidemiology, diagnosis, and management of cardiovascular disease in women - chapter 5: sex- and gender-unique manifestations of cardiovascular disease.CJC Open. 2022; 4: 243-262
- Breastfeeding and maternal hypertension.Am. J. Hypertens. 2018; 31: 615-621
- 2016 European guidelines on cardiovascular disease prevention in clinical practice.Rev. Esp. Cardiol. (Engl. Ed.). 2016; 69: 939
- 2021 Canadian cardiovascular society guidelines for the Management of Dyslipidemia for the prevention of cardiovascular disease in adults.Can. J. Cardiol. 2021; 37: 1129-1150
- Pregnancy-related cardiovascular risk indicators: primary care approach to postpartum management and prevention of future disease.Can. Fam. Physician. 2019; 65: 883-889
- Sex differences in hypertension: where we have been and where we are going.Am. J. Hypertens. 2018; 31: 1247-1254
- The renin-angiotensin-aldosterone system in postmenopausal women: the promise of hormone therapy.Mayo Clin. Proc. 2021; 96: 3130-3141
- Vascular effects of early versus late postmenopausal treatment with estradiol.N. Engl. J. Med. 2016; 374: 1221-1231
- The kronos early estrogen prevention study (KEEPS): what have we learned?.Menopause. 2019; 26: 1071-1084
- The 2017 hormone therapy position statement of the North American Menopause Society.Menopause. 2017; 24: 728-753
- Post-menopausal hypertension: detecting, treating, accompany, prevent.Presse Med. 2019; 48: 1288-1294
- Hot flashes: emerging cardiovascular risk factors in recent and late postmenopause and their association with higher blood pressure.Menopause. 2016; 23: 846-855
- Hypertension prevalence and control among adults: United States, 2011–2014.NCHS Data Brief. 2015; 220: 1-8
- A randomized trial of intensive versus standard blood-pressure control.N. Engl. J. Med. 2016; 374: 2294
- Sex differences of patients with systemic hypertension (From the analysis of the systolic blood pressure intervention trial [SPRINT]).Am. J. Cardiol. 2018; 122: 985-993
- Hypertension in older adults: assessment, management, and challenges.Clin. Cardiol. 2020; 43: 99-107
- Hypertension management in older and frail older patients.Circ. Res. 2019; 124: 1045-1060
- Racial differences in hypertension: implications for high blood pressure management.Am. J. Med. Sci. 2014; 348: 135-138
- Racial disparity in pregnancy risks and complications in the US: temporal changes during 2007–2018.J. Clin. Med. 2020; 9
- The Canadian Women's Heart Health Alliance ATLAS on the epidemiology, diagnosis, and management of cardiovascular disease in women-chapter 2: scope of the problem.CJC Open. 2021; 3: 1-11
- Effect of nurse-directed hypertension treatment among first nations people with existing hypertension and diabetes mellitus: the diabetes risk evaluation and microalbuminuria (DREAM 3) randomized controlled trial.CMAJ. 2006; 174: 1267-1271
- State-of-the-art diagnosis and treatment of hypertension in pregnancy.Mayo Clin. Proc. 2018; 93: 1664-1677
- 206: use of hormonal contraception in women with coexisting medical conditions.Obstet. Gynecol. 2019; 133: e128-e150
- Use of the oral contraceptive pill is associated with increased large artery stiffness in young women: the ENIGMA study.J. Hypertens. 2011; 29: 1155-1159
- The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women.Osteoporos. Int. 2007; 18: 479-486
- Age and sex disparities in hypertension control: the multi-ethnic study of atherosclerosis (MESA).Am. J. Prev. Cardiol. 2021; 8100230
- Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.Eur. Heart J. 2008; 29: 2669-2680
- Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs.Eur. J. Clin. Pharmacol. 2018; 74: 1165-1173
Article info
Publication history
Published online: December 06, 2022
Accepted:
November 12,
2022
Received in revised form:
November 1,
2022
Received:
June 4,
2022
Identification
Copyright
© 2022 Elsevier B.V. All rights reserved.
